Regulatory Updates
Aug 27, 2026•1 min read
FDA Approves Multiple Submissions for SCANDONEST L Injection (Discontinued)
The FDA record shows SCANDONEST L injectable, containing levonordefrin and mepivacaine, has a discontinued marketing status and a history of approved labeling and manufacturing submissions dating from 1984 to 2018.
Regulatory Updates
Aug 25, 2026•1 min read
FDA ANDA 086095: Watson Labs Chlorpheniramine Injection Discontinued
The FDA lists ANDA 086095 for Watson Labs' chlorpheniramine maleate injectable (100 mg/mL). The product is marked discontinued.
1
Regulatory Updates
Aug 23, 2026•1 min read
Orbit Pharma Recalls Cyclizine Lactate Injection Batch Over GMP Deficiencies
Orbit Pharma Limited is recalling a batch of Cyclizine Lactate 50 mg/ml injection solution due to GMP deficiencies at the manufacturing site.
1